LB Pharmaceuticals Inc (LBRX)

LB Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	14.73	23.48	14.98
Short-Term Investments	0	5.02	28.31
Cash & Cash Equivalents	14.73	28.5	43.29
Cash Growth	-48.30%	-34.17%	-
Other Current Assets	0.05	0.38	2.34
Total Current Assets	14.78	28.88	45.63
Property, Plant & Equipment	3.96	4.16	0.02
Other Long-Term Assets	0.51	0.5	0
Total Long-Term Assets	4.47	4.66	0.02
Total Assets	19.25	33.53	45.66
Accounts Payable	0.64	2.32	1.39
Current Debt	0.73	0.49	0
Other Current Liabilities	2.54	5.3	1.22
Total Current Liabilities	3.91	8.11	2.61
Long-Term Debt	3.03	3.22	0
Other Long-Term Liabilities	1.93	2.5	1.56
Total Long-Term Liabilities	4.96	5.72	1.56
Total Liabilities	8.86	13.83	4.16
Total Debt	3.76	3.7	0
Retained Earnings	-114.5	-104.32	-41.22
Comprehensive Income	0	0.11	0.27
Shareholders' Equity	-103.87	-94.55	-34.47
Net Cash (Debt)	10.97	24.79	43.29
Net Cash (Debt) Growth	-55.75%	-42.73%	-
Net Cash Per Share	-	2.44	5.40
Working Capital	10.88	20.77	43.03
Book Value Per Share	-30.25	-9.29	-4.30

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).